Correlation Between Hana Microelectronics and Inter Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hana Microelectronics and Inter Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hana Microelectronics and Inter Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hana Microelectronics Public and Inter Pharma Public, you can compare the effects of market volatilities on Hana Microelectronics and Inter Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hana Microelectronics with a short position of Inter Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hana Microelectronics and Inter Pharma.

Diversification Opportunities for Hana Microelectronics and Inter Pharma

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Hana and Inter is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Hana Microelectronics Public and Inter Pharma Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inter Pharma Public and Hana Microelectronics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hana Microelectronics Public are associated (or correlated) with Inter Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inter Pharma Public has no effect on the direction of Hana Microelectronics i.e., Hana Microelectronics and Inter Pharma go up and down completely randomly.

Pair Corralation between Hana Microelectronics and Inter Pharma

Assuming the 90 days trading horizon Hana Microelectronics Public is expected to under-perform the Inter Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Hana Microelectronics Public is 18.14 times less risky than Inter Pharma. The stock trades about -0.05 of its potential returns per unit of risk. The Inter Pharma Public is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  692.00  in Inter Pharma Public on October 22, 2024 and sell it today you would lose (404.00) from holding Inter Pharma Public or give up 58.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Hana Microelectronics Public  vs.  Inter Pharma Public

 Performance 
       Timeline  
Hana Microelectronics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hana Microelectronics Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Inter Pharma Public 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inter Pharma Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental drivers remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Hana Microelectronics and Inter Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hana Microelectronics and Inter Pharma

The main advantage of trading using opposite Hana Microelectronics and Inter Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hana Microelectronics position performs unexpectedly, Inter Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inter Pharma will offset losses from the drop in Inter Pharma's long position.
The idea behind Hana Microelectronics Public and Inter Pharma Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation